The G20210A mutation is a genetic alteration in the prothrombin gene, leading to increased levels of prothrombin in the blood and a heightened risk of venous thromboembolism. This mutation is inherited in an autosomal dominant pattern, meaning only one copy of the altered gene is necessary to increase the risk of clotting disorders.